Related Experiment Video
Updated: Sep 12, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
MACRO SOLUTIONS TO A MICRO PROBLEM: DRUG-RESISTANT PNEUMOCOCCAL PNEUMONIA
1Boston, MA.
Abstract:
Even before the COVID-19 pandemic, acute respiratory infections represented one of the most common reasons for patients to seek urgent medical care. S. pneumoniae is one of the most frequent bacterial causes of acute respiratory infections, especially community-acquired pneumonia. In the latter part of the twentieth century, the emergence of multidrug resistance among clinical isolates of S. pneumoniae threatened to render standard empiric antibiotic therapy ineffective. One of the biggest drivers of pneumococcal drug resistance is antibiotic overuse, among both adults and children. While the introduction of the pneumococcal conjugate vaccine in 2000 dramatically impacted the overall incidence of pneumococcal pneumonia in both children and adults, the levels of antibiotic resistance have remained significant. To reduce the overuse of antibiotics requires multidimensional interventions targeting patients, clinicians, and health systems. Studies have demonstrated improvement in this area, but the quality gap remains high. Future work will focus on organizational strategies and policies that optimize antibiotic use for patients with antibiotic responsive acute illnesses.
Insights
Antibiotic overuse fuels drug resistance in Streptococcus pneumoniae, a leading cause of pneumonia. Multidimensional interventions are crucial to optimize antibiotic use and combat rising resistance, despite vaccine advancements.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Acute respiratory infections are a major reason for urgent medical care.
- Streptococcus pneumoniae (S. pneumoniae) is a primary bacterial cause of community-acquired pneumonia.
- Multidrug resistance in S. pneumoniae emerged in the late 20th century, threatening standard antibiotic treatments.
Purpose of the Study:
- To address the significant levels of antibiotic resistance in S. pneumoniae.
- To explore strategies for reducing antibiotic overuse in patients with acute respiratory illnesses.
- To identify multidimensional interventions targeting patients, clinicians, and health systems.
Main Methods:
- Review of existing literature on antibiotic resistance trends in S. pneumoniae.
- Analysis of factors contributing to antibiotic overuse.
- Evaluation of the impact of the pneumococcal conjugate vaccine.
- Assessment of current interventions aimed at optimizing antibiotic use.
Main Results:
- Antibiotic overuse, in both adults and children, is a major driver of pneumococcal drug resistance.
- The pneumococcal conjugate vaccine (introduced in 2000) reduced overall pneumococcal pneumonia incidence but did not eliminate significant antibiotic resistance.
- Despite improvements, a substantial quality gap remains in optimizing antibiotic use.
Conclusions:
- Reducing antibiotic overuse requires comprehensive strategies involving patients, clinicians, and healthcare systems.
- Organizational strategies and policies are needed to optimize antibiotic prescribing for responsive acute illnesses.
- Continued efforts are necessary to mitigate the threat of multidrug-resistant S. pneumoniae infections.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

